Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence
Europace · 02.06.2026 · 28 (6)
DOI: 10.1093/europace/euag130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 03.06.2026. Verfasst von Shaylyn Joseph und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Labatt Family Heart Centre and Translational Medicine, The Hospital for Sick Children & Research Institute and the Univ…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research Team.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, The Labatt Family Heart Centre and Translational Medicine, The Hospital for Sick Children & Research Institute and the University of Toronto, Room 1725D, 555 University Avenue, Toronto, ON M5G…
- Department of Congenital Heart Diseases, National Institute of Cardiology, 42 Alpejska Str., Warsaw 04-628, Poland.
- Clinical Research Support Centre, National Institute of Cardiology, 42 Alpejska Str., Warsaw 04-628, Poland.
ORCID-Profile: Shaylyn Joseph, Karolina Borowiec, Olgierd Woźniak, Diptendu Chatterjee, Meena Fatah, Vivian Silbiger, Ewa Kowalik, Mirosław Kowalski, Elżbieta Katarzyna Biernacka, Robert M Hamilton
Förderung
- Canadian Institutes of Health Research Team
Zitieren
APA
Joseph, S., Borowiec, K., Woźniak, O., Chatterjee, D., Fatah, M., Silbiger, V., Kowalik, I., Skrzypczyńska-Banasik, U., Kowalik, E., Kowalski, M., Biernacka, E. K., & Hamilton, R. M. (2026). Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence. Europace, 28(6). https://doi.org/10.1093/europace/euag130
Vancouver
Joseph S, Borowiec K, Woźniak O, Chatterjee D, Fatah M, Silbiger V, et al. Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence. Europace. 2026;28(6). doi:10.1093/europace/euag130
BibTeX
@article{Joseph2026,
author = {Joseph, Shaylyn and Borowiec, Karolina and Woźniak, Olgierd and Chatterjee, Diptendu and Fatah, Meena and Silbiger, Vivian and Kowalik, Ilona and Skrzypczyńska-Banasik, Urszula and Kowalik, Ewa and Kowalski, Mirosław and Biernacka, Elżbieta Katarzyna and Hamilton, Robert M},
title = {Clinical value of anti-desmoglein-2 antibodies in arrhythmogenic right ventricular cardiomyopathy: real-world evidence},
journal = {Europace},
year = {2026},
volume = {28},
number = {6},
doi = {10.1093/europace/euag130}
}
EUVIMED